Trial Profile

Flortaucipir (18F) PET Imaging in the BIOCARD Study

Status: Discontinued

Phase of Trial: Phase I

Latest Information Update: 09 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Flortaucipir-F-18 (Primary)
Indications Cognition disorders
Focus Diagnostic use
Sponsors Avid Radiopharmaceuticals

Most Recent Events

30 Jul 2021 Results presented at the Alzheimer's Association International Conference 2021
07 Dec 2018 Status changed from recruiting to discontinued study terminated due to lower than expected enrollment
01 Mar 2018 Planned End Date changed from 31 Jan 2018 to 31 Jan 2019.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com